Tenofovir: profile and news
MSF Supports Opposition To Gilead's Tenofovir Patent Application ... May 10, 2006
...support for Indian civil society groups in their battle against a patent application by Gilead Sciences for the key AIDS drug tenofovir (tenofovir disoproxil ... - Doctors Without Borders,
Patients oppose patent for Aids drug tenofovir May 11, 2006
NEW DELHI: Groups of HIV/Aids patients in India yesterday opposition US pharma major Gilead’s patent application for the key Aids drug tenofovir, saying the ... - Gulf Times,
SLU Liver Center to study effectiveness of tenofovir in treating ... May 3, 2006
The drug under investigation in the study, called Tenofovir, is similar to Hepsera in that it is a "nucleotide analog" that helps stop the virus from ... - News-Medical.net,
HIV Pharmacology Workshop: Explaining tenofovir renal toxicities ... May 2, 2006
Interactions between tenofovir and protease inhibitors appear to be governed by a wider range of drug transporters than previously assumed, according to ... - Aidsmap,
Gilead's AIDS drug patent faces patient networks' opposition May 10, 2006
GSK) patent application on the AIDS-medicine Combivir, HIV/AIDS patient networks have now opposed the patent application on another AIDS-drug, Tenofovir. ... - Sify,
AIDS drug provokes patent battle in India May 11, 2006
If the drug, tenofovir, is granted a patent, the manufacture of cheaper versions in India will become illegal, making the drug too expensive for patients in ... - International Herald Tribune,
Additional oppn against AIDS drug patent May 13, 2006
The legal challenge to the patent application in India filed in Delhi last week by two patients’ rights groups against ‘tenofovir’, the AIDS drug, will ... - Mid-Day Mumbai,
Indians march on parliament over Aids drug patent May 10, 2006
Living with HIV/AIDS and the Delhi Network of Positive People this week registered a pre-grant opposition to the patenting of tenofovir disoproxil fumarate ... - Financial Times,
Patent Issue: AIDS shall cost dearer? May 14, 2006
...and Delhi asking the government to prevent Gilead Sciences from patenting the antiretroviral drug Viread, available under the brand names Tenofovir and Norvir ... - International Reporter,
NGOs against Indian patent for AIDS drug May 10, 2006
...and representatives of HIV/AIDS patients Wednesday opposed US pharma major Gilead Sciences’ move to seek an Indian patent for AIDS drug Tenofovir as this ... - India eNews.com,
Agreement lowers price of drug distributed to HIV victims May 10, 2006
BrasÃlia - The Ministry of Health will save over US$ 31 million in its purchases of the drug Tenofovir. The drug is one of the ... - Agencia Brasil,
AIDS Drug Provokes Legal Fight in India May 11, 2006
Germany. Two patient rights groups sued to stop the drug tenofovir, which is available as a generic drug, from being granted a patent. ... - New York Times,
NGOs protest against AIDS drug patent May 11, 2006
Network of Positive People registered their pre-grant opposition to a patent application filed by Gilead Sciences in India on Tenofovir Disoproxil Fumarate (TDF ... - Times of India,
HIV/AIDS Advocacy Groups File Opposition to Gilead's Request for ... May 12, 2006
...application with the New Delhi patent office to oppose Gilead's application to patent its antiretroviral drug Viread, known generically as tenofovir, the AP ... - Kaiser network.org,
US Drug Company Accused Of Making HIV Meds Unaffordable In India May 14, 2006
Gilead has applied for an Indian patent on the drug tenofovir, which has been available in India as the generic tenofovir disoproxil fumarate since last year. ... - 365Gay.com
AIDS Groups in India Sue to Halt Patent for US Drug May 12, 2006
...stop Gilead Sciences, a California biopharmaceutical company, from patenting the antiretroviral drug Viread — its brand-name version of tenofovir, which is ... - New York Times,
AIDS Groups in India Sue to Halt Patent for US Drug May 11, 2006
Sciences, a California biopharmaceutical company, from patenting the antiretroviral drug Viread — the company's brand-name version of tenofovir, which is ... - New York Times,
Patent fight in India centers on AIDS drug May 11, 2006
NEW DELHI, May 11 (UPI) -- A patent application covering tenofovir, a major AIDS drug, has started a major patent fight in India. ... - United Press International
Patent Fight in India Centers on AIDS Drug May 11, 2006
A patent application covering tenofovir, a major AIDS drug, has started a major patent fight in India. If the drug is granted a ... - International News Service,
India drug challenge vital to poorest AIDS patients: health groups May 11, 2006
The suit against a patent application filed by California-based Gilead Sciences involves a drug called tenofovir disoproxil fumarate, which has fewer known ... - TODAYonline,
Microbides 2006: what products are in the pipeline? May 2, 2006
A related study in Nigeria is still continuing, however, while a study comparing Savvy and tenofovir gel vs. placebo is being planned. ... - Aidsmap,
Patent of AIDs Drug Opposed May 11, 2006
New Delhi, India (AHN) - Several groups have opposed the patent application of key AIDS drug Tenofovir Disoproxil Fumarate (TDF). ... - All Headline News
Indians protest patent for anti-aids drug May 10, 2006
The company, Gilead Sciences Inc., has applied for an Indian patent on the drug tenofovir, which has been available in India as the generic tenofovir ... - Business Day,
Brazilian Health Ministry, Gilead Reach Price Reduction Agreement ... May 11, 2006
...on Tuesday announced that it has reached an agreement with Gilead to reduce by half the price the government pays for the antiretroviral drug tenofovir for use ... - Kaiser network.org,
HIV drug may help treat hepatitis B May 4, 2006
Saint Louis University School of Medicine researchers are investigating the drug Tenofovir, similar to Hepsera in that it is a "nucleotide analog" that helps ... - United Press International
Brazil, Gilead agree AIDS drug price cut May 10, 2006
Gilead Sciences will slash by half the price of its drug tenofovir, used in an anti-AIDS cocktail, Brazil's Health Ministry said. ... - TODAYonline,
Humans to test AIDS drug May 13, 2006
...in Thailand, San Francisco and Atlanta, to see people can be shielded from the AIDS virus by one of the drugs in Truvada - Viread, also known as tenofovir. ... - Bradenton Herald,
Bristol-Myers Squibb en Gilead dienen aanvraag in bij FDA voor ... Apr 27, 2006
New Drug Application to US FDA for a Once-Daily Single Tablet Regimen of Sustiva(R) (Efavirenz) and Truvada(R) (Emtricitabine and Tenofovir Disoproxil Fumarate ... - Netherlands Corporate News (persbericht),
International Approvals: Sifrol/Mirapexin and Truvada Apr 24, 2006
Health Canada has approved once-daily tenofovir plus emtricitabine 300-mg/200-mg tablets for use in combination with other antiretroviral agents in the ... - Medscape (subscription)
Bristol-Myers Squibb and Gilead Sciences Submit New Drug ... Apr 27, 2006
...combines the anti-HIV medications Sustiva(R) (efavirenz), manufactured by Bristol-Myers Squibb, and Truvada(R) (emtricitabine and tenofovir disoproxil fumarate ... - International News Service,
a cure for aids Apr 24, 2006
...intercourse. The gel includes a dose of tenofovir, an AIDS drug normally given orally to people already infected with the virus. ... - ProgressiveU.org,
Drug firms seek to stop generic HIV treatment May 10, 2006
Gilead has sought a patent on a key Aids treatment called tenofovir (Viread), while Glaxo has sought one for a widely used drug called Combivir. ... - Guardian Unlimited,
Foster City firm's AIDS drug ready for human trials May 12, 2006
Thailand, San Francisco and Atlanta, to see whether people can be shielded from the AIDS virus by one of the drugs in Truvada -- Viread, also known as tenofovir ... - San Jose Mercury News,
Liver transplants can be successful in HIV patients with Hepatitis ... May 2, 2006
Almost half of these patients were taking additional anti-HBV medications (tenofovir and/or adefovir) that are effective against lamivudine-resistant HBV. ... - Hindu,
Activists: Deny patent to Gilead May 11, 2006
Allowing Gilead to patent Viread, also known as tenofovir, would stop Indian companies from making cheaper copies of the drug until 2018, Doctors Without ... - Inside Bay Area,
AHF APPLAUDS GILEAD SCIENCES FOR MOVE TO INCREASE GLOBAL ACCESS TO ... May 11, 2006
...announcement that it is pursuing non-exclusive, voluntary licensing to generic manufacturers in India for its AIDS drug Viread (tenofovir disoproxil fumarate ... - ITNews,
Liver transplantation can be successful in patients co-infected ... May 4, 2006
Three of these patients were resistant to 3TC, and received hepatitis B immunoglobulin (HBIG), 3TC and tenofovir (Viread) or adefovir (Hepsera). ... - Aidsmap,
Can Drugs Prevent HIV? Apr 27, 2006
Currently, there are five studies around the globe that are investigating the use of either tenofovir or truvada for so called pre-exposure prophylaxis (PrEP). ... - Gay City News
UC Receives $3.4 Million NIH Grant To Study Treatment For HIV And ... Apr 17, 2006
In what is known as highly active antiretroviral therapy (HAART), three or more antiviral medications such as efavirenz, tenofovir and emtricitibine are taken ... - Medical News Today (press release),
Hepatits B Drug May Have Uses For HIV Patients May 3, 2006
Medical professionals are currently investigating the drug called Tenofovir, which is very similar to Hepsera in that it is a “nucleotide analog� that ... - All Headline News
Gilead Sciences Announces First Quarter 2006 Financial Results Apr 18, 2006
...be driven primarily by Gilead's HIV product franchise, including the continued robust performance of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate ... - Genetic Engineering News,
Is diabetes a complication of HIV infection? May 7, 2006
...one week later, he started co-trimoxazole prophylaxis and an anti-HIV drug combination of 200mg FTC (emtricitabine, Emtriva), 300mg tenofovir (Viread) and six ... - Aidsmap,
Natural Mutation Confers Drug Resistance on HBV Apr 26, 2006
Journal of Medicine. The virus in all three patients was sensitive to Viread (tenofovir), the authors reported. "Our observations ... - MedPage Today,
Variant of Hepatitis B Virus with Primary Resistance to Adefovir Apr 26, 2006
...resistance. Here, we describe three cases of primary adefovir resistance that were sensitive to tenofovir (Viread, Gilead). All ... - New England Journal of Medicine (subscription),
10% of New HIV Cases Have Virus Mutation Associated With ... Apr 26, 2006
...is more likely than subtype B, found mainly in North America and Europe, to develop a mutation that is resistant to some antiretroviral drugs, such as tenofovir ... - Kaiser network.org,
FDA asked to approve once-a-day HIV pill Apr 28, 2006
The product combines Bristol-Myers Squibb' anti-HIV medication Sustiva (efavirenz) and Gilead's Truvada (emtricitabine and tenofovir disoproxil fumarate). ... - Trenton Times,
Starting treatment with Kaletra involves greater risk of increased ... Apr 24, 2006
...race, sex, age, CD4 cell count, duration of anti-HIV therapy or hepatitis C infection, the investigators noted that patients taking tenofovir (Viread and 3TC ... - Aidsmap,
Gilead, Bristol-Myers Squibb Submit Once-a-Day Combination ... Apr 28, 2006
The pill submitted for approval includes 200 milligrams of emticitabine and 300 milligrams of tenofovir -- the two generic antiretrovirals included in Truvada ... - Kaiser network.org,
HIV is a disease and not meant to be a scare tactic Apr 17, 2006
Last month, the Centers for Disease Control reported that they have developed a combination of pills - tenofovir and emtricitabine - that could fully prevent ... - Virginia Tech Collegiate Times Online Edition,
National Roundup Apr 19, 2006
The two drugs are tenofovir ( Viread ) and emtricitabine, or FTC ( Emtriva ) , sold in combination as Truvada by Gilead Sciences Inc. ... - Windy City Times,
